Bio-Rad's Expanding Profit Margins and Stake in Sartorius Drive Long-Term Value
As of 2023 year-end, the firm had $1.2 billion of debt, $1.6 billion of cash and cash equivalents, and $1.5 billion of deferred taxes that are largely related to its Sartorius investment. We forecast ...
cbdMD targets growth with new product launches and improved profitability in Q1 2025
Q1 2025 Management View Interim CEO and CFO Ronan Kennedy highlighted the company’s focus on achieving profitability and resolving capital structure challenges. He stated, “We delivered on our ...